180 related articles for article (PubMed ID: 26979595)
21. Development of recombinant matrix metalloproteinase-3 based sandwich ELISA for sero-diagnosis of canine mammary carcinomas.
Pandey M; Kumar BV; Singh S; Verma R
J Immunoassay Immunochem; 2017; 38(1):34-44. PubMed ID: 27404490
[TBL] [Abstract][Full Text] [Related]
22. Molecular Characterization and In-Silico Analysis of the Tissue Inhibitor of Metalloproteinases-3 (TIMP-3) Gene of Canine Mammary Tumor.
Yadav PK; Yadav BS; Panigrahi PN; Tripathi V; Chaturvedi N; Kataria M
Comb Chem High Throughput Screen; 2017; 20(6):539-546. PubMed ID: 28215146
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of ATM Gene and Protein Expression in Canine Mammary Tumors.
Raposo-Ferreira TM; Bueno RC; Terra EM; Avante ML; Tinucci-Costa M; Carvalho M; Cassali GD; Linde SD; Rogatto SR; Laufer-Amorim R
Vet Pathol; 2016 Nov; 53(6):1154-1159. PubMed ID: 27106737
[TBL] [Abstract][Full Text] [Related]
24. The metastatic cascade is reflected in the transcriptome of metastatic canine mammary carcinomas.
Klopfleisch R; Lenze D; Hummel M; Gruber AD
Vet J; 2011 Nov; 190(2):236-243. PubMed ID: 21112801
[TBL] [Abstract][Full Text] [Related]
25. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
26. Possible role of Snail expression as a prognostic factor in canine mammary neoplasia.
Im KS; Kim JH; Kim NH; Yu CH; Hur TY; Sur JH
J Comp Pathol; 2012; 147(2-3):121-8. PubMed ID: 22297072
[TBL] [Abstract][Full Text] [Related]
27. Expression of matrix metalloproteinases, their inhibitors, and lysyl oxidase in myocardial samples from dogs with end-stage systemic and cardiac diseases.
Fonfara S; Hetzel U; Tew SR; Cripps P; Dukes-McEwan J; Clegg PD
Am J Vet Res; 2013 Feb; 74(2):216-23. PubMed ID: 23363345
[TBL] [Abstract][Full Text] [Related]
28. CD44 and CD24 Expression and Prognostic Significance in Canine Mammary Tumors.
Rogez B; Pascal Q; Bobillier A; Machuron F; Lagadec C; Tierny D; Le Bourhis X; Chopin V
Vet Pathol; 2019 May; 56(3):377-388. PubMed ID: 30558511
[TBL] [Abstract][Full Text] [Related]
29. Insulin receptor is expressed in normal canine mammary gland and benign adenomas but decreased in metastatic canine mammary carcinomas similar to human breast cancer.
Klopfleisch R; Hvid H; Klose P; da Costa A; Gruber AD
Vet Comp Oncol; 2010 Dec; 8(4):293-301. PubMed ID: 21062411
[TBL] [Abstract][Full Text] [Related]
30. Expression patterns of connexin 26 and connexin 43 mRNA in canine benign and malignant mammary tumours.
Gotoh H; Harada K; Suzuki K; Hashimoto S; Yamamura H; Sato T; Fukumoto K; Hagiwara H; Ishida T; Yamada K; Asano R; Yano T
Vet J; 2006 Jul; 172(1):178-80. PubMed ID: 16772144
[TBL] [Abstract][Full Text] [Related]
31. Expression patterns of the slit subfamily mRNA in canine malignant mammary tumors.
Tanno T; Tanaka Y; Sugiura T; Akiyoshi H; Takenaka S; Kuwamura M; Yamate J; Ohashi F; Kubo K; Tsuyama S
J Vet Med Sci; 2006 Nov; 68(11):1173-7. PubMed ID: 17146174
[TBL] [Abstract][Full Text] [Related]
32. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue.
Kubota T; Itagaki M; Hoshino C; Nagata M; Morozumi T; Kobayashi T; Takagi R; Yoshie H
J Periodontol; 2008 Jan; 79(1):166-73. PubMed ID: 18166107
[TBL] [Abstract][Full Text] [Related]
33. Expression of genes encoding matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in normal and diseased canine mitral valves.
Aupperle H; Thielebein J; Kiefer B; März I; Dinges G; Schoon HA; Schubert A
J Comp Pathol; 2009 May; 140(4):271-7. PubMed ID: 19285315
[TBL] [Abstract][Full Text] [Related]
34. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
35. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
Gama A; Alves A; Schmitt F
Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
[TBL] [Abstract][Full Text] [Related]
36. Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines.
Ahern TE; Bird RC; Bird AE; Wolfe LG
Am J Vet Res; 1996 May; 57(5):693-6. PubMed ID: 8723884
[TBL] [Abstract][Full Text] [Related]
37. Activation of Mammalian target of rapamycin in canine mammary carcinomas: an immunohistochemical study.
Delgado L; Gärtner F; Dias Pereira P
J Comp Pathol; 2015; 152(2-3):138-44. PubMed ID: 25670666
[TBL] [Abstract][Full Text] [Related]
38. Loss of p27 expression in canine mammary tumors and their metastases.
Klopfleisch R; Schütze M; Gruber AD
Res Vet Sci; 2010 Apr; 88(2):300-3. PubMed ID: 19748645
[TBL] [Abstract][Full Text] [Related]
39. Expression frequency of c-kit isoforms and its prognostic potential in canine mammary tumours.
Chen YC; Liao JW; Chang SC; Hsu WL
Vet Comp Oncol; 2020 Sep; 18(3):303-314. PubMed ID: 31652393
[TBL] [Abstract][Full Text] [Related]
40. Identification of novel tumour-associated antigens in canine mammary gland tumour.
Furuya M; Funasaki M; Tani H; Sasai K
Vet Comp Oncol; 2015 Sep; 13(3):194-202. PubMed ID: 23510442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
